Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”

Detalles Bibliográficos
Autores principales: Uebelhack, Ralf, Bongartz, Udo, Seibt, Stephanie, Bothe, Gordana, Chong, Pee Win, De Costa, Patricia, Wszelaki, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657607/
https://www.ncbi.nlm.nih.gov/pubmed/31380115
http://dx.doi.org/10.1155/2019/6189724
_version_ 1783438817933393920
author Uebelhack, Ralf
Bongartz, Udo
Seibt, Stephanie
Bothe, Gordana
Chong, Pee Win
De Costa, Patricia
Wszelaki, Natalia
author_facet Uebelhack, Ralf
Bongartz, Udo
Seibt, Stephanie
Bothe, Gordana
Chong, Pee Win
De Costa, Patricia
Wszelaki, Natalia
author_sort Uebelhack, Ralf
collection PubMed
description
format Online
Article
Text
id pubmed-6657607
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-66576072019-08-04 Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects” Uebelhack, Ralf Bongartz, Udo Seibt, Stephanie Bothe, Gordana Chong, Pee Win De Costa, Patricia Wszelaki, Natalia J Obes Erratum Hindawi 2019-07-11 /pmc/articles/PMC6657607/ /pubmed/31380115 http://dx.doi.org/10.1155/2019/6189724 Text en Copyright © 2019 Ralf Uebelhack et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Erratum
Uebelhack, Ralf
Bongartz, Udo
Seibt, Stephanie
Bothe, Gordana
Chong, Pee Win
De Costa, Patricia
Wszelaki, Natalia
Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
title Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
title_full Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
title_fullStr Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
title_full_unstemmed Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
title_short Erratum to “Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects”
title_sort erratum to “double-blind, randomized, three-armed, placebo-controlled, clinical investigation to evaluate the benefit and tolerability of two dosages of iqp-ae-103 in reducing body weight in overweight and moderately obese subjects”
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657607/
https://www.ncbi.nlm.nih.gov/pubmed/31380115
http://dx.doi.org/10.1155/2019/6189724
work_keys_str_mv AT uebelhackralf erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects
AT bongartzudo erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects
AT seibtstephanie erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects
AT bothegordana erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects
AT chongpeewin erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects
AT decostapatricia erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects
AT wszelakinatalia erratumtodoubleblindrandomizedthreearmedplacebocontrolledclinicalinvestigationtoevaluatethebenefitandtolerabilityoftwodosagesofiqpae103inreducingbodyweightinoverweightandmoderatelyobesesubjects

Ejemplares similares